KL-50: A Novel Therapeutic Agent Targeting MGMT-Deficient Glioblastoma. Zhang K, Touat M, Khasraw M. Neuro Oncol 2025 Jan 8:noaf001. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Zhang K, Touat M, Khasraw M. KL-50: A Novel Therapeutic Agent Targeting MGMT-Deficient Glioblastoma. Neuro Oncol 2025 Jan 8:noaf001. doi: 10.1093.
PMID: 39777476